ReviewPharmaceutical nanotechnology2025
A Significant Prospective on Nanorobotics in Precision Medicine and Therapeutic Interventions.
Review in Pharmaceutical nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut-kidney-brain axis and daytime sleepiness in Parkinson's disease and chronic kidney disease: an expert narrative review.Frontiers in aging neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nanorobotics, situated at the intersection of nanotechnology and robotics, holds the potential for revolutionary impact on precision medicine and medical interventions. This review explores the design, navigation, drug delivery, and applications of nanorobots. Architectural intricacies, sensor integration, and navigation strategies, both active and passive, are discussed. Nanorobots are poised to play a pivotal role in controlled drug delivery and personalized medicine, including disease-specific targeting. Their applications span across various domains, including cancer therapy, neurological interventions, and emerging fields. Despite the promises, challenges such as technological hurdles, regulatory considerations, and safety concerns are also acknowledged. The review anticipates a transformative impact on healthcare, offering a comprehensive guide for researchers, clinicians, and policymakers navigating the evolving landscape of nanorobotics.
Indexed as
Identifiers
39328130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.